Hosted by Jill Malandrino, TradeTalks broadcasts live from MarketSite in Times Square and Global Industry Conferences and Events. Featuring conversations with top industry thought leaders on trends, news and education.
Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.
Driving Excellence: Realizing Responsibility with Trevor Manuel
In this episode, Byron Loflin, Global Head of Board Advisory at Nasdaq, is joined by Trevor Manuel, Chairman at Old Mutual. Trevor discusses the differences between South African and U.S. boardrooms while highlighting the importance of maintaining a clear separation of powers between the boards and management teams.
To celebrate Kopin’s 31st listing anniversary, CEO Michael Murray discusses the company's mission, its future ambitions and how being #NasdaqListed empowers Kopin to pursue its goal of innovating AR, VR and Metaverse technologies.
What Options for the Debt Ceiling Are Available to Congressional Leaders?
Pacific Research Institute Senior Fellow in Business & Economics Dr. Wayne Winegarden joins Jill Malandrino on Nasdaq TradeTalks to discuss what options for the debt ceiling are available to Congressional leaders on both sides of the aisle and the impact to the economy.
In this episode of Breakthrough Economy, we discuss the shifts and advances we saw in biotech in 2022, and what's to come in 2023 and beyond for this innovative sector. Host Jen Rogers is joined by George Yancopoulos, co-founder, president and chief scientific officer at Regeneron and managing director and senior biotech analyst at Oppenheimer, Hartaj Singh.
ECARX Chairman and CEO Ziyu Shen reflects on the company's mission and how listing on Nasdaq empowers ECARX to pursue its goal in becoming the computing platform for the next-generation of electric vehicles.
Acrivon Therapeutics President, CEO and founder Peter Blume-Jensen gives advice to aspiring entrepreneurs, speaks to the role Acrivon Therapeutics is playing in the new era of precision medicine and how being Nasdaq-listed is making it all possible.